Kiniksa Pharmaceuticals
KNSA
KNSA
160 hedge funds and large institutions have $773M invested in Kiniksa Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 58 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $991M → $773M (-$218M)
44% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 34
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
160
Holding in Top 10
1
Calls
$2.39M
Puts
$2.41M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$10.6M | |
| 3 | +$6.34M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6.31M |
| 5 |
Millennium Management
New York
|
+$6.01M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$7.56M | |
| 3 | -$6.78M | |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$6.17M |
| 5 |
BlackRock
New York
|
-$5.6M |